Exhaled nitric oxide in a population-based study of asthma and allergy in schoolchildren.
Exhaled nitric oxide (NO) reflects inflammation in the lower airways and is well adapted for use in children. The aims of this study were to investigate the distribution of the fraction of expired NO (FENO) in school children and to compare FENO and spirometry in relation to the International Study of Asthma and Allergies in Childhood questionnaire. The study was performed in 959 randomly selected 13-14-year-old school children in Uppsala, Sweden. Exhaled NO was measured at an inhalation rate of 0.1 l/s (FENO0.1) and a spirometric test was performed and data from these measurements were related to questionnaire data. Exhaled NO was measured according to American Thoracic Society recommendations, except the use of a mouth wash and an exhalation flow rate of 0.1 l/s. The distribution of the mean FENO0.1 values was skewed, with a preponderance of very low levels and a widespread tail of values ranging up to 102 parts per billion (ppb). Boys exhibited significantly higher mean FENO0.1 values than girls, 5.2 (4.7-5.7) vs 4.4 (4.0-4.8) ppb (geometric mean and 95% CI), P <0.01). Children who reported wheezing in the last year had higher FENO0.1 values than children that had not, 8.5 (7.1-10.2) vs 4.3 (4.0-4.6) ppb, P <0.001). The same association was found to most symptoms indicating hay fever and eczema. In contrast to this, only weak or inconsistent associations were found between asthma and spirometric indices. Exhaled NO levels were found to be independently related to male gender, wheeze and rhinoconjuctivitis but not to current eczema. In conclusion, exhaled NO was closely associated with reported asthma and allergy symptoms whereas spirometric indices such as percent predicted forced expiratory volume in 1 s were not. As most asthma cases in a population are mild, the findings suggest that exhaled NO is a sensitive marker of asthma and allergy.
Nordvall
S L
SL
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Janson
C
C
Kalm-Stephens
P
P
Foucard
T
T
Torén
K
K
Alving
K
K
D000293:Adolescent; D001249:Asthma / Q000453:epidemiology / Q000503:physiopathology*; D003876:Dermatitis, Atopic / Q000503:physiopathology; D045853:Exhalation; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology / Q000503:physiopathology*; D008297:Male; D009569:Nitric Oxide; D015995:Prevalence; D012135:Respiratory Sounds; D012220:Rhinitis / Q000453:epidemiology; D006255:Rhinitis, Allergic, Seasonal / Q000503:physiopathology; D012720:Severity of Illness Index; D013147:Spirometry; D013334:Students; D011795:Surveys and Questionnaires
D009569:Nitric Oxide